{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T11:53:16Z","timestamp":1791287596678,"version":"4.1.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Cancer Res Clin Oncol"],"published-print":{"date-parts":[[2011,8]]},"DOI":"10.1007\/s00432-011-0986-0","type":"journal-article","created":{"date-parts":[[2011,5,27]],"date-time":"2011-05-27T05:26:31Z","timestamp":1306473991000},"page":"1203-1211","source":"Crossref","is-referenced-by-count":41,"title":["Molecular profiles of EGFR, K-ras, c-met, and FGFR in pulmonary pleomorphic carcinoma, a rare lung malignancy"],"prefix":"10.1007","volume":"137","author":[{"given":"Soohyeon","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youngwook","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jong-Mu","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoon La","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jhin Gook","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young-Mog","family":"Shim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yeon Hee","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin Seok","family":"Ahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keunchil","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jung Ho","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Myung-Ju","family":"Ahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,5,28]]},"reference":[{"key":"986_CR1","doi-asserted-by":"crossref","first-page":"3860","DOI":"10.1158\/1078-0432.CCR-07-4608","volume":"14","author":"MJ Ahn","year":"2008","unstructured":"Ahn MJ, Park BB, Ahn JS, Kim SW, Kim HT, Lee JS, Kang JH, Cho JY, Song HS, Park SH, Sohn CH, Shin SW, Choi JH, Ki CS, Park CK, Holmes AJ, Janne PA, Park K (2008) Are there any ethnic differences in molecular predictors of erlotinib efficacy in advanced non-small cell lung cancer? Clin Cancer Res 14:3860\u20133866","journal-title":"Clin Cancer Res"},{"key":"986_CR2","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1620\/tjem.206.181","volume":"206","author":"N Arita","year":"2005","unstructured":"Arita N, Mikami Y, Yoshida M, Konishi I, Horiike N, Miyauchi K, Miyazaki T, Nose M, Ono M (2005) Pleomorphic carcinoma of the lung associated with loss of heterozygosity of p53 gene. Tohoku J Exp Med 206:181\u2013185","journal-title":"Tohoku J Exp Med"},{"key":"986_CR3","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.lungcan.2007.05.006","volume":"58","author":"HM Bae","year":"2007","unstructured":"Bae HM, Min HS, Lee SH, Kim DW, Chung DH, Lee JS, Kim YW, Heo DS (2007) Palliative chemotherapy for pulmonary pleomorphic carcinoma. Lung Cancer 58:112\u2013115","journal-title":"Lung Cancer"},{"key":"986_CR4","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1053\/j.ro.2005.01.001","volume":"40","author":"MB Beasley","year":"2005","unstructured":"Beasley MB, Brambilla E, Travis WD (2005) The 2004 world health organization classification of lung tumors. Semin Roentgenol 40:90\u201397","journal-title":"Semin Roentgenol"},{"key":"986_CR5","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1007\/s00428-006-0256-8","volume":"449","author":"M Blaukovitsch","year":"2006","unstructured":"Blaukovitsch M, Halbwedl I, Kothmaier H, Gogg-Kammerer M, Popper HH (2006) Sarcomatoid carcinomas of the lung\u2013are these histogenetically heterogeneous tumors? Virchows Arch 449:455\u2013461","journal-title":"Virchows Arch"},{"key":"986_CR6","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0169-5002(01)00224-0","volume":"34","author":"YL Chang","year":"2001","unstructured":"Chang YL, Lee YC, Shih JY, Wu CT (2001) Pulmonary pleomorphic (spindle) cell carcinoma: peculiar clinicopathologic manifestations different from ordinary non-small cell carcinoma. Lung Cancer 34:91\u201397","journal-title":"Lung Cancer"},{"key":"986_CR7","doi-asserted-by":"crossref","first-page":"3408","DOI":"10.1158\/1535-7163.MCT-08-0444","volume":"7","author":"H Fischer","year":"2008","unstructured":"Fischer H, Taylor N, Allerstorfer S, Grusch M, Sonvilla G, Holzmann K, Setinek U, Elbling L, Cantonati H, Grasl-Kraupp B, Gauglhofer C, Marian B, Micksche M, Berger W (2008) Fibroblast growth factor receptor-mediated signals contribute to the malignant phenotype of non-small cell lung cancer cells: therapeutic implications and synergism with epidermal growth factor receptor inhibition. Mol Cancer Ther 7:3408\u20133419","journal-title":"Mol Cancer Ther"},{"key":"986_CR8","doi-asserted-by":"crossref","first-page":"2936","DOI":"10.1002\/1097-0142(19940615)73:12<2936::AID-CNCR2820731210>3.0.CO;2-U","volume":"73","author":"NF Fishback","year":"1994","unstructured":"Fishback NF, Travis WD, Moran CA, Guinee DG Jr, McCarthy WF, Koss MN (1994) Pleomorphic (spindle\/giant cell) carcinoma of the lung. A clinicopathologic correlation of 78 cases. Cancer 73:2936\u20132945","journal-title":"Cancer"},{"key":"986_CR9","doi-asserted-by":"crossref","first-page":"2538","DOI":"10.1158\/1078-0432.CCR-05-2845","volume":"12","author":"SW Han","year":"2006","unstructured":"Han SW, Kim TY, Jeon YK, Hwang PG, Im SA, Lee KH, Kim JH, Kim DW, Heo DS, Kim NK, Chung DH, Bang YJ (2006) Optimization of patient selection for gefitinib in non-small cell lung cancer by combined analysis of epidermal growth factor receptor mutation, K-ras mutation, and Akt phosphorylation. Clin Cancer Res 12:2538\u20132544","journal-title":"Clin Cancer Res"},{"key":"986_CR10","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1200\/JCO.20.6.1692","volume":"20","author":"MC Heinrich","year":"2002","unstructured":"Heinrich MC, Blanke CD, Druker BJ, Corless CL (2002) Inhibition of KIT tyrosine kinase activity: a novel molecular approach to the treatment of KIT-positive malignancies. J Clin Oncol 20:1692\u20131703","journal-title":"J Clin Oncol"},{"key":"986_CR11","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/s12032-008-9117-4","volume":"26","author":"JY Hong","year":"2009","unstructured":"Hong JY, Choi MK, Uhm JE, Park MJ, Lee J, Park YH, Ahn JS, Park K, Han JH, Ahn MJ (2009) The role of palliative chemotherapy for advanced pulmonary pleomorphic carcinoma. Med Oncol 26:287\u2013291","journal-title":"Med Oncol"},{"key":"986_CR12","doi-asserted-by":"crossref","first-page":"2479","DOI":"10.1002\/ijc.24610","volume":"125","author":"A Italiano","year":"2009","unstructured":"Italiano A, Cortot AB, Ilie M, Martel-Planche G, Fabas T, Pop D, Mouroux J, Hofman V, Hofman P, Pedeutour F (2009) EGFR and KRAS status of primary sarcomatoid carcinomas of the lung: implications for anti-EGFR treatment of a rare lung malignancy. Int J Cancer 125:2479\u20132482","journal-title":"Int J Cancer"},{"key":"986_CR13","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.lungcan.2009.06.002","volume":"68","author":"K Ito","year":"2010","unstructured":"Ito K, Oizumi S, Fukumoto S, Harada M, Ishida T, Fujita Y, Harada T, Kojima T, Yokouchi H, Nishimura M (2010) Clinical characteristics of pleomorphic carcinoma of the lung. Lung Cancer 68:204\u2013210","journal-title":"Lung Cancer"},{"key":"986_CR14","doi-asserted-by":"crossref","first-page":"L1488","DOI":"10.1152\/ajplung.00147.2006","volume":"292","author":"R Jagadeeswaran","year":"2007","unstructured":"Jagadeeswaran R, Jagadeeswaran S, Bindokas VP, Salgia R (2007) Activation of HGF\/c-Met pathway contributes to the reactive oxygen species generation and motility of small cell lung cancer cells. Am J Physiol Lung Cell Mol Physiol 292:L1488\u2013L1494. doi: 10.1152\/ajplung.00147.2006","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"986_CR15","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1097\/JTO.0b013e3181ce3e3c","volume":"5","author":"K Kaira","year":"2010","unstructured":"Kaira K, Horie Y, Ayabe E, Murakami H, Takahashi T, Tsuya A, Nakamura Y, Naito T, Endo M, Kondo H, Nakajima T, Yamamoto N (2010) Pulmonary pleomorphic carcinoma: a clinicopathological study including EGFR mutation analysis. J Thorac Oncol 5:460\u2013465","journal-title":"J Thorac Oncol"},{"key":"986_CR16","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1002\/ijc.24150","volume":"124","author":"T Kubo","year":"2009","unstructured":"Kubo T, Yamamoto H, Lockwood WW, Valencia I, Soh J, Peyton M, Jida M, Otani H, Fujii T, Ouchida M, Takigawa N, Kiura K, Shimizu K, Date H, Minna JD, Varella-Garcia M, Lam WL, Gazdar AF, Toyooka S (2009) MET gene amplification or EGFR mutation activate MET in lung cancers untreated with EGFR tyrosine kinase inhibitors. Int J Cancer 124:1778\u20131784","journal-title":"Int J Cancer"},{"key":"986_CR17","first-page":"6272","volume":"63","author":"PC Ma","year":"2003","unstructured":"Ma PC, Kijima T, Maulik G, Fox EA, Sattler M, Griffin JD, Johnson BE, Salgia R (2003) c-MET mutational analysis in small cell lung cancer: novel juxtamembrane domain mutations regulating cytoskeletal functions. Cancer Res 63:6272\u20136281","journal-title":"Cancer Res"},{"key":"986_CR18","first-page":"620","volume":"8","author":"G Maulik","year":"2002","unstructured":"Maulik G, Kijima T, Ma PC, Ghosh SK, Lin J, Shapiro GI, Schaefer E, Tibaldi E, Johnson BE, Salgia R (2002) Modulation of the c-Met\/hepatocyte growth factor pathway in small cell lung cancer. Clin Cancer Res 8:620\u2013627","journal-title":"Clin Cancer Res"},{"key":"986_CR19","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1097\/PAS.0b013e3181804302","volume":"32","author":"T Mochizuki","year":"2008","unstructured":"Mochizuki T, Ishii G, Nagai K, Yoshida J, Nishimura M, Mizuno T, Yokose T, Suzuki K, Ochiai A (2008) Pleomorphic carcinoma of the lung: clinicopathologic characteristics of 70 cases. Am J Surg Pathol 32:1727\u20131735","journal-title":"Am J Surg Pathol"},{"key":"986_CR20","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1126\/science.1095920","volume":"303","author":"ME Noble","year":"2004","unstructured":"Noble ME, Endicott JA, Johnson LN (2004) Protein kinase inhibitors: insights into drug design from structure. Science 303:1800\u20131805","journal-title":"Science"},{"key":"986_CR21","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1097\/JTO.0b013e3181d0a4db","volume":"5","author":"T Onitsuka","year":"2010","unstructured":"Onitsuka T, Uramoto H, Ono K, Takenoyama M, Hanagiri T, Oyama T, Izumi H, Kohno K, Yasumoto K (2010) Comprehensive molecular analyses of lung adenocarcinoma with regard to the epidermal growth factor receptor, K-ras, MET, and hepatocyte growth factor status. J Thorac Oncol 5:591\u2013596","journal-title":"J Thorac Oncol"},{"key":"986_CR22","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1038\/modpathol.3800058","volume":"17","author":"G Pelosi","year":"2004","unstructured":"Pelosi G, Scarpa A, Manzotti M, Veronesi G, Spaggiari L, Fraggetta F, Nappi O, Benini E, Pasini F, Antonello D, Iannucci A, Maisonneuve P, Viale G (2004) K-ras gene mutational analysis supports a monoclonal origin of biphasic pleomorphic carcinoma of the lung. Mod Pathol 17:538\u2013546","journal-title":"Mod Pathol"},{"key":"986_CR23","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1177\/1066896908330049","volume":"18","author":"G Pelosi","year":"2010","unstructured":"Pelosi G, Sonzogni A, De Pas T, Galetta D, Veronesi G, Spaggiari L, Manzotti M, Fumagalli C, Bresaola E, Nappi O, Viale G, Rosai J (2010) Review article: pulmonary sarcomatoid carcinomas: a practical overview. Int J Surg Pathol 18:103\u2013120","journal-title":"Int J Surg Pathol"},{"key":"986_CR24","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1097\/00000478-200303000-00004","volume":"27","author":"G Rossi","year":"2003","unstructured":"Rossi G, Cavazza A, Sturm N, Migaldi M, Facciolongo N, Longo L, Maiorana A, Brambilla E (2003) Pulmonary carcinomas with pleomorphic, sarcomatoid, or sarcomatous elements: a clinicopathologic and immunohistochemical study of 75 cases. Am J Surg Pathol 27:311\u2013324","journal-title":"Am J Surg Pathol"},{"key":"986_CR25","doi-asserted-by":"crossref","first-page":"S52","DOI":"10.1053\/j.seminoncol.2009.02.008","volume":"36","author":"R Salgia","year":"2009","unstructured":"Salgia R (2009) Role of c-Met in cancer: emphasis on lung cancer. Semin Oncol 36:S52\u2013S58","journal-title":"Semin Oncol"},{"key":"986_CR26","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1093\/jjco\/hyn155","volume":"39","author":"A Ushiki","year":"2009","unstructured":"Ushiki A, Koizumi T, Kobayashi N, Kanda S, Yasuo M, Yamamoto H, Kubo K, Aoyagi D, Nakayama J (2009) Genetic heterogeneity of EGFR mutation in pleomorphic carcinoma of the lung: response to gefitinib and clinical outcome. Jpn J Clin Oncol 39:267\u2013270","journal-title":"Jpn J Clin Oncol"}],"container-title":["Journal of Cancer Research and Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.springerlink.com\/index\/pdf\/10.1007\/s00432-011-0986-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,19]],"date-time":"2017-06-19T20:52:21Z","timestamp":1497905541000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00432-011-0986-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,5,28]]},"references-count":26,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2011,8]]}},"alternative-id":["986"],"URL":"https:\/\/doi.org\/10.1007\/s00432-011-0986-0","relation":{},"ISSN":["0171-5216","1432-1335"],"issn-type":[{"value":"0171-5216","type":"print"},{"value":"1432-1335","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,5,28]]}}}